European Heart Journal Advance Access published online on December 9, 2004
European Heart Journal, doi:10.1093/eurheartj/ehi064
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
* To whom correspondence should be addressed. Aims The present study aimed to determine the frequency and the impact on clinical outcome of atrial fibrillation (AF) in patients with acute myocardial infarction (AMI) and left ventricular dysfunction. Methods and results In the OPTIMAAL trial, 5477 patients with AMI and signs of left ventricular dysfunction were included. At baseline, 655 patients (12%) had AF, and 345 (7.2%) developed new-onset AF during follow-up (2.7 ± 0.9 years). Older patients, patients with history of angina and worse Killip class had and developed AF more frequently (P < 0.001). Patients with AF at baseline were at increased risk relative to those without AF for mortality [adjusted hazard ratio (HR) of 1.32, P = 0.001] and for stroke (HR 1.77, P < 0.001). New-onset AF was associated with increased subsequent mortality for the first 30 days following randomization (HR 3.83, P < 0.001) and the entire trial period (HR 1.82, P < 0.001). Risk of stroke was increased for the first 30 days (HR 14.6, P < 0.001) and for the whole trial period (HR 2.29, P < 0.001). Conclusion AF is frequently observed in patients with AMI complicated by heart failure. Current AF, and the development of new AF soon after AMI, is associated with increased risk of death and stroke.
Clinical research
Prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience
2 Merck Research Laboratories, West Point, PA, USA; Amgen, Thousand Oaks, CA, USA
3 University of Bergen, Cardiology Division, Central Hospital in Rogaland, Stavanger, Norway
4 Department of Medicine, Sahlgrenska University Hospital, Göteborg, Sweden
Mika Lehto, E-mail: mika.lehto{at}fimnet.fi
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. Whang and K. W. Davidson Is It Time to Treat Depression in Patients With Cardiovascular Disease? Circulation, July 14, 2009; 120(2): 99 - 100. [Full Text] [PDF] |
||||
![]() |
A. Goette, A. Bukowska, D. Dobrev, J. Pfeiffenberger, H. Morawietz, D. Strugala, I. Wiswedel, F.-W. Rohl, C. Wolke, S. Bergmann, et al. Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles Eur. Heart J., June 1, 2009; 30(11): 1411 - 1420. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schmitt, G. Duray, B. J. Gersh, and S. H. Hohnloser Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications Eur. Heart J., May 1, 2009; 30(9): 1038 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cappato Atrial fibrillation complicating acute myocardial infarction: how should it be interpreted and how should it be treated and prevented? Eur. Heart J., May 1, 2009; 30(9): 1035 - 1037. [Full Text] [PDF] |
||||
![]() |
F. G. Cosío, J.#x. Palacios, A.#x.;n Pastor, and A. Núñez CHAPTER 2 The Electrocardiogram ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Hylek, L. Frison, L. E. Henault, and A. Cupples Disparate Stroke Rates on Warfarin Among Contemporaneous Cohorts With Atrial Fibrillation: Potential Insights Into Risk From a Comparative Analysis of SPORTIF III Versus SPORTIF V Stroke, November 1, 2008; 39(11): 3009 - 3014. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Roy, M. Talajic, S. Nattel, D. G. Wyse, P. Dorian, K. L. Lee, M. G. Bourassa, J. M. O. Arnold, A. E. Buxton, A. J. Camm, et al. Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure N. Engl. J. Med., June 19, 2008; 358(25): 2667 - 2677. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Siu, M.-H. Jim, H.-H. Ho, R. Miu, S. W.L. Lee, C.-P. Lau, and H.-F. Tse Transient Atrial Fibrillation Complicating Acute Inferior Myocardial Infarction: Implications for Future Risk of Ischemic Stroke Chest, July 1, 2007; 132(1): 44 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Boos, R. A. Anderson, and G. Y.H. Lip Is atrial fibrillation an inflammatory disorder? Eur. Heart J., January 2, 2006; 27(2): 136 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Stenestrand, J. Lindback, L. Wallentin, and for the RIKS-HIA Registry Anticoagulation Therapy in Atrial Fibrillation in Combination With Acute Myocardial Infarction Influences Long-Term Outcome: A Prospective Cohort Study From the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA) Circulation, November 22, 2005; 112(21): 3225 - 3231. [Abstract] [Full Text] [PDF] |
||||





